# Study Found CBD and CBG May Counter Fatty Liver Disease​ | Cannabis Sciences > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/hepatoprotective-effects-cbd-cbg-fatty-liver-disease/ > **Published:** 2026-03-17T10:24:15-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:06:05-04:00 > **Clinical Summary:** Explore hepatoprotective effects CBD CBG may offer in fatty liver disease, highlighting emerging research and clinical relevance for metabolic health. --- ✦ New CED Clinical Relevance** #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchCBDAgingSafety Why This Matters Clinicians managing patients with non-alcoholic [fatty liver disease](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/) may benefit from understanding emerging preclinical evidence on cannabinoids, as CBD and CBG show potential hepatoprotective effects that could inform future treatment discussions and [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/). This research is particularly relevant for geriatric populations and patients with metabolic syndrome, where fatty liver disease represents a growing clinical burden and current treatment options remain limited. However, clinicians should recognize this as early-stage research requiring further human trials before recommending cannabinoid-based interventions as standard care. Clinical Summary A recent study published in Age and Ageing examined the potential therapeutic effects of cannabidiol (CBD) and cannabigerol (CBG) on fatty liver disease in older adults, finding that these cannabinoids may help reduce hepatic fat accumulation and improve liver function markers. The research suggests that CBD and CBG could work through anti-inflammatory and antioxidant mechanisms to mitigate liver injury, which is particularly relevant given the rising prevalence of non-alcoholic fatty liver disease across aging populations. These findings have direct implications for clinicians treating older patients with metabolic syndrome or obesity-related liver complications, as cannabinoid-based interventions could potentially offer an adjunctive therapeutic option beyond current standard care. However, clinicians should note that further clinical trials with larger sample sizes and longer follow-up periods are needed before recommending CBD or CBG as a primary treatment strategy. The pharmacokinetic variability and lack of standardized dosing guidelines for these cannabinoids in liver disease populations remain significant barriers to clinical implementation. Clinicians considering cannabis-derived products for patients with fatty liver disease should counsel patients on the preliminary nature of this evidence while monitoring liver function tests if use is pursued. Dr. Caplan’s Take “What we’re seeing in the emerging research on cannabinoids like CBD and CBG is a genuine pharmacological signal in metabolic disease, particularly nonalcoholic fatty liver disease, which means we need to stop dismissing these compounds and start designing rigorous clinical trials to understand dosing, duration, and which patients benefit most rather than waiting another decade for consensus.” Clinical Perspective While emerging preclinical evidence suggests cannabidiol and cannabigerol may have hepatoprotective properties against fatty liver disease, clinicians should recognize that in vitro and animal model findings do not yet translate reliably to human therapeutic efficacy. Current evidence in human subjects remains limited, and the long-term safety profile of cannabis-derived cannabinoids in patients with existing liver disease—who may have altered drug metabolism—is incompletely characterized. Additionally, cannabis products vary considerably in cannabinoid content and purity, and many are unregulated, creating uncertainty about what patients actually consume. Rather than recommending cannabis for non-alcoholic fatty liver disease at this time, providers should continue to emphasize established interventions such as weight loss, metabolic disease management, and alcohol avoidance, while staying informed about clinical trials that may eventually clarify whether specific cannabinoids offer genuine benefit in this population. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Study+Found+CBD+and+CBG+May+Counter+Fatty+Liver+Disease%E2%80%8B+%7C+Cannabis+Sciences+%40drcaplan&url=https%3A%2F%2Fwww.labroots.com%2Ftrending%2Fcannabis-sciences%2F30310%2Fstudy-found-cbd-cbg-counter-fatty-liver-disease-2)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.labroots.com%2Ftrending%2Fcannabis-sciences%2F30310%2Fstudy-found-cbd-cbg-counter-fatty-liver-disease-2)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Study+Found+CBD+and+CBG+May+Counter+Fatty+Liver+Disease%E2%80%8B+%7C+Cannabis+Sciences+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.labroots.com%2Ftrending%2Fcannabis-sciences%2F30310%2Fstudy-found-cbd-cbg-counter-fatty-liver-disease-2)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [AM News Update: March 16, 2026](https://cedclinic.com/cannabis-use-by-older-adults-mental-decline-2026/) - [AM News Update: March 16, 2026](https://cedclinic.com/cannabis-use-by-older-adults-mental-decline-2026/) - [Cannabis** Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health](https://cedclinic.com/metabolic-associated-fatty-liver-disease-cbd-cbg-liver-fat/) 📰 Source: [https://www.labroots.com/trending/cannabis-sciences/30310/study-found-cbd-cbg-counter-fatty-liver-disease-2](https://www.labroots.com/trending/cannabis-sciences/30310/study-found-cbd-cbg-counter-fatty-liver-disease-2) Further Reading Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Research Digest[AM Policy Update: March 17, 2026](https://cedclinic.com/dea-synthetic-opioids-schedule-i-march-17-2026/) CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis Compounds CBD and CBG Show Promise in Fighting Fatty Liver Disease](https://cedclinic.com/cbd-and-cbg-fatty-liver-research/) This article explores how CBD and CBG compounds may help reduce fatty liver disease through anti-inflammatory and antioxidant mechanisms. [Read More](https://cedclinic.com/cbd-and-cbg-fatty-liver-research/) [Two Compounds Found in Cannabis Plant Reverse Liver Disease Damage, Study Suggests](https://cedclinic.com/cannabis-compounds-reverse-liver-disease-damage/) Discover findings on how cannabis-derived compounds may reverse liver damage, offering new insights into potential treatments. [Explore Study](https://cedclinic.com/cannabis-compounds-reverse-liver-disease-damage/) [Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health](https://cedclinic.com/metabolic-associated-fatty-liver-disease-cbd-cbg-liver-fat/) Learn about the promising effects of CBD and CBG in reducing liver fat and improving metabolic health markers. [Learn More](https://cedclinic.com/metabolic-associated-fatty-liver-disease-cbd-cbg-liver-fat/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).